These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 12695037

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model.
    Gaafar MR, El-Mansoury ST, Eissa MM, Shalaby TI, Younis LK, Rashed HA.
    Acta Trop; 2022 Jan; 225():106215. PubMed ID: 34687647
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.
    Gong P, Cao L, Guo Y, Dong H, Yuan S, Yao X, Ren W, Yao L, Xu Z, Sun Q, Zhang X.
    Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254
    [Abstract] [Full Text] [Related]

  • 46. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
    Cui X, Lei T, Yang D, Hao P, Li B, Liu Q.
    Vaccine; 2012 Mar 16; 30(13):2282-7. PubMed ID: 22310204
    [Abstract] [Full Text] [Related]

  • 47. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients.
    Meira CS, Costa-Silva TA, Vidal JE, Ferreira IMR, Hiramoto RM, Pereira-Chioccola VL.
    J Med Microbiol; 2008 Jul 16; 57(Pt 7):845-850. PubMed ID: 18566142
    [Abstract] [Full Text] [Related]

  • 48. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
    Zorgi NE, Galisteo AJ, Sato MN, do Nascimento N, de Andrade HF.
    Med Microbiol Immunol; 2016 Aug 16; 205(4):297-314. PubMed ID: 26732075
    [Abstract] [Full Text] [Related]

  • 49. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.
    Parasite Immunol; 2005 Aug 16; 27(1-2):29-35. PubMed ID: 15813720
    [Abstract] [Full Text] [Related]

  • 50. Toxoplasma gondii excretory secretory antigenic proteins of diagnostic potential.
    Saadatnia G, Mohamed Z, Ghaffarifar F, Osman E, Moghadam ZK, Noordin R.
    APMIS; 2012 Jan 16; 120(1):47-55. PubMed ID: 22151308
    [Abstract] [Full Text] [Related]

  • 51. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.
    Parmley S, Slifer T, Araujo F.
    J Infect Dis; 2002 Feb 15; 185 Suppl 1():S90-5. PubMed ID: 11865445
    [Abstract] [Full Text] [Related]

  • 52. [Study on immune response in BALB/c mice induced by ROP2 protein of Toxoplasma gondii with cimetidine].
    Chen XZ, Yang XD, Yang W, Chen Y, Liu LL, Shen JL, Sun X.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Apr 15; 31(2):99-103. PubMed ID: 24809187
    [Abstract] [Full Text] [Related]

  • 53. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H.
    Exp Parasitol; 2012 May 15; 131(1):133-8. PubMed ID: 22445587
    [Abstract] [Full Text] [Related]

  • 54. Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection.
    Decoster A, Darcy F, Capron A.
    Clin Exp Immunol; 1988 Sep 15; 73(3):376-82. PubMed ID: 3208449
    [Abstract] [Full Text] [Related]

  • 55. Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
    Wang LJ, Xiao T, Xu C, Li J, Liu GZ, Yin K, Cui Y, Wei QK, Huang BC, Sun H.
    Vaccine; 2018 Jun 22; 36(27):3943-3948. PubMed ID: 29793893
    [Abstract] [Full Text] [Related]

  • 56. Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection.
    Wang HL, Pang M, Yin LT, Zhang JH, Meng XL, Yu BF, Guo R, Bai JZ, Zheng GP, Yin GR.
    Acta Trop; 2014 Sep 22; 137():58-66. PubMed ID: 24813415
    [Abstract] [Full Text] [Related]

  • 57. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice.
    Cui YL, He SY, Xue MF, Zhang J, Wang HX, Yao Y.
    Parasite Immunol; 2008 May 22; 30(5):309-13. PubMed ID: 18331395
    [Abstract] [Full Text] [Related]

  • 58. [Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii].
    Li JH, Wu ST, Weng YB, Gan Y, Liu HB, Liu ML, Zhang RL, Gao ST, Huang DN, Geng YJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun 22; 25(3):217-21. PubMed ID: 18038782
    [Abstract] [Full Text] [Related]

  • 59. Partially purified Toxoplasma gondii antigens by immunoaffinity chromatography.
    Ahn MH, Hyun KH, Kang JO, Min DY.
    Korean J Parasitol; 1997 Dec 22; 35(4):251-8. PubMed ID: 9446906
    [Abstract] [Full Text] [Related]

  • 60. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
    Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, Zhang NZ, Zhu XQ.
    Vaccine; 2013 Mar 25; 31(13):1734-9. PubMed ID: 23370151
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.